| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| USRE39861 | TEVA BRANDED PHARM | Methods of extended use oral contraception |
Jun, 2017
(6 years ago) | |
| US5898032 | TEVA BRANDED PHARM | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
Jun, 2017
(6 years ago) | |
Seasonale is owned by Teva Branded Pharm.
Seasonale contains Ethinyl Estradiol; Levonorgestrel.
Seasonale has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Seasonale are:
- USRE39861
- US5898032
Seasonale was authorised for market use on 05 September, 2003.
Seasonale is available in tablet;oral dosage forms.
Seasonale can be used as prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception, prevention of pregnancy.
The generics of Seasonale are possible to be released after 23 June, 2017.
Drugs and Companies using ETHINYL ESTRADIOL; LEVONORGESTREL ingredient
Market Authorisation Date: 05 September, 2003
Treatment: Prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception; Prevention of pregnancy
Dosage: TABLET;ORAL
SEASONALE family patents
